Otsuka (OTCMKTS:OTSKY) Share Price Crosses Above 50-Day Moving Average – Here’s What Happened

Shares of Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY) crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $34.11 and traded as high as $35.48. Otsuka shares last traded at $35.37, with a volume of 28,470 shares trading hands.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on OTSKY. UBS Group raised shares of Otsuka to a “hold” rating in a research report on Tuesday, January 27th. The Goldman Sachs Group downgraded shares of Otsuka from a “strong-buy” rating to a “strong sell” rating in a research report on Friday, February 27th. Zacks Research raised shares of Otsuka from a “strong sell” rating to a “hold” rating in a research report on Tuesday, March 31st. Finally, Morgan Stanley raised shares of Otsuka to an “overweight” rating in a research report on Friday, January 23rd. One investment analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold”.

Otsuka Price Performance

The company has a current ratio of 2.17, a quick ratio of 1.67 and a debt-to-equity ratio of 0.05. The firm has a market cap of $37.99 billion and a PE ratio of 14.92. The stock has a 50 day simple moving average of $34.11 and a 200-day simple moving average of $30.89.

Otsuka (OTCMKTS:OTSKY) last issued its quarterly earnings results on Tuesday, April 28th. The company reported $0.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.43 by $0.16. Otsuka had a return on equity of 12.33% and a net margin of 15.01%.The business had revenue of $3.96 billion during the quarter, compared to analyst estimates of $3.78 billion. Otsuka has set its FY 2026 guidance at 1.610-1.610 EPS. Equities analysts anticipate that Otsuka Holdings Co., Ltd. – Unsponsored ADR will post 1.86 earnings per share for the current fiscal year.

About Otsuka

Otsuka Pharmaceutical Co, Ltd., trading in the U.S. under the ticker OTCMKTS:OTSKY, is a global healthcare company headquartered in Tokyo, Japan. The firm’s core activities span the development, manufacturing and marketing of prescription pharmaceuticals, consumer healthcare products and nutraceuticals. Otsuka focuses its research on areas such as neuroscience, cardiovascular and renal therapies, and oncology, aiming to bring innovative treatments to patients worldwide.

Founded in 1964 by Busaburo Otsuka as a subsidiary of the Otsuka Group, the company has grown into a diversified healthcare enterprise over more than five decades.